Table 3.
Regression analysis results of factors associated with MDR/RR-TB surveillance.
| Variable | Level | Modified Poisson regression analysis | |||
|---|---|---|---|---|---|
| Unadjusted analysis (RR, 95% CI) |
Adjusted analysis (aRR, 95% CI) |
||||
| GeneXpert at site | No | Ref | Ref | ||
| Yes | 2.29* | (1.04,5.00) | 1.52 | (0.81,2.86) | |
| Year of treatment | 2015 | Ref | Ref | ||
| 1 year increase | 1.95⁎⁎⁎ | (1.53,2.50) | 1.77⁎⁎⁎ | (1.39,2.25) | |
| Sex | Male | Ref | |||
| Female | 0.36* | (0.14,0.94) | 0.54 | (0.21,1.37) | |
| Type of previously treated persons with bacteriologically confirmed pulmonary tuberculosis | Relapse | Ref | Ref | ||
| Failure | 0.25* | (0.06,0.96) | 0.28* | (0.08,0.95) | |
| Lost to follow-up | 0.56 | (0.26,1.20) | 0.66 | (0.32,1.39) | |
Note: (1) *p < 0.05;
⁎⁎⁎
p < 0.001 at 5% significance level; (2) All risk ratios (RR) and 95% confidence intervals (CI) in brackets (3) aRR: Adjusted RR; (4) RR: Unadjusted RR.